Arrowhead Research Corporation (NASDAQ:ARWR) went lower by -1.57% to close at $ 4.39. The company exchanged total volume of 1.96 thousand shares throughout course of last trade however it holds an average trading capacity of 1.02 million shares.
The company is trading below its 50-day moving averages of 5.64 and down from 200-day moving averages of 6.10. The firm has price to book ratio of 4.49 and its price to sale ratio was 1586.02.
According to ZACKS data, different Brokerage Firms rated ARWR stock about their BUY, SELL or HOLD recommendations. Currently shares have been suggested as BUY from 0 brokerage firms and recommended as Strong Buy by 4 brokerage firms.0 brokerage firms have issued Sell rating for the company and Strong Sell rating was issued by 0 brokerage firms.1 brokerage firms have rated the company as a Hold. The Corporation has average brokerage recommendation (ABR) of 1.4 based on consensus of the brokerage firms issuing ratings.
The average true range of Arrowhead Pharmaceuticals, Inc.’s (ARWR) is recorded at 0.33 and the relative strength index of the stock stands 34.92. The stock price is going above to its 52 week low with 43.00% and lagging behind from its 52 week high with -46.59%. Analyst recommendation for this stock stands at 2.20. A look on the firm performance, its monthly performance is -25.15% and a quarterly performance of -37.99%. The stock price is trading downbeat from its 200 days moving average with -23.72% and down from 50 days moving average with -28.16%.
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) dropped -0.98% and closed the trade at $ 10.15. The company recorded a trading capacity of 0 shares below its three months average daily volume of 375.06 thousand shares. The stock’s 50-day moving average is noted at $9.76 and its 200-day moving average is stands at $11.20.
Additionally, the company has a PE ratio of 14.50 and has EPS of 0.70. The company has market capitalization of $518.19M.
SciClone Pharmaceuticals, Inc.’s (SCLN) has price to sale ratio of 3.26. The company net profit margin is 23.20% and gross profit margin is 85.90%. A look on the firm performance, its monthly performance is 14.69% and a quarterly performance of -1.36%. The stock price is moving up from its 20 days moving average with 4.29% and isolated positively from 50 days moving average with 2.04%.